Market Overview

Benzinga's Top Pre-Market Gainers

Related IN
Morning Market Movers
Intermec To Be Acquired by Honeywell for $600M
Related HON
RBC Capital Technicians Like Financials And Tech, Sees Asset Managers Weakening
Determining The True Value Of 3M
Can Honeywell (HON) Maintain the Earnings Momentum in Q3? (Zacks)

Intermec (NYSE: IN) moved up 24.37% to $9.90 in the pre-market session. Honeywell International (NYSE: HON) announced its plans to buy Intermec for $600 million.

Cyclacel Pharmaceuticals (NASDAQ: CYCC) soared 6.98% to $6.90 in the pre-market trading. Cyclacel Pharmaceuticals announced updated survival data from the pilot study and lead-in phase of SEAMLESS Phase 3 study.

Celldex Therapeutics (NASDAQ: CLDX) added 6.88% to $5.90 in the pre-market session. Celldex Therapeutics announced final results from the company's randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer.

Ingersoll-Rand Plc (NYSE: IR) surged 2.28% to $49.80 in the pre-market session. Ingersoll-Rand announced its plans to spin off its security division.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (CLDX + CYCC)

View Comments and Join the Discussion!

Get Benzinga's Newsletters